2021
DOI: 10.1016/j.ymeth.2020.01.011
|View full text |Cite
|
Sign up to set email alerts
|

In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
105
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 206 publications
(129 citation statements)
references
References 37 publications
0
105
0
2
Order By: Relevance
“…Human-based computational approaches have now built momentum beyond academia, reaching clinical, industrial, and regulatory environments. They provide virtual tools, embedding our knowledge on human physiology, to investigate disease, and develop and evaluate therapeutic interventions ( Rodriguez et al., 2016 ; Morrison et al., 2018 ; Viceconti et al., 2020 ). Recent studies have, for example, demonstrated the ability of biophysical human-based modelling and simulation for the assessment of the safety and efficacy of pharmacological therapies ( Sarkar and Sobie, 2011 ; Passini et al., 2017 , 2019 ; Li et al., 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…Human-based computational approaches have now built momentum beyond academia, reaching clinical, industrial, and regulatory environments. They provide virtual tools, embedding our knowledge on human physiology, to investigate disease, and develop and evaluate therapeutic interventions ( Rodriguez et al., 2016 ; Morrison et al., 2018 ; Viceconti et al., 2020 ). Recent studies have, for example, demonstrated the ability of biophysical human-based modelling and simulation for the assessment of the safety and efficacy of pharmacological therapies ( Sarkar and Sobie, 2011 ; Passini et al., 2017 , 2019 ; Li et al., 2019 ).…”
Section: Introductionmentioning
confidence: 99%
“…While model validation is always limited to a given set of inputs and outputs, using models or methodologies outside their validation range is where computational modelling can become useful, providing new information. This should be performed with clear identification of the context of use (Viceconti et al 2020), justifying using appropriate variation in inputs or outputs with respect to the validation study. Systematically providing comprehensive information on model methodologies ("the art of modelling") and on the physical data used in validation studies (input and output data) would provide better confidence in the context of use of "valid" models and increase the possibility to directly compare model methodologies against the same physical data.…”
Section: Discussionmentioning
confidence: 99%
“…Validation of in silico model is the process of making sure that the right equations are solved, and the correct parameters are used for a given scenario. A model is never "valid" for all possible scenarios and applications; a validation process is linked to a specific question of interest (Viceconti et al 2020).…”
Section: Introductionmentioning
confidence: 99%
“…They will transform the research and medical device industry, reduce the need for in-vivo tests and be a complementary part of the product life cycle. However, computer models need to be verified, validated, and analysed for uncertainties [14]. There are still challenges in computer models such as scaling and merging to describe an entire organism or at least a significant part of it before we can use them to as pre-clinical test tools [15].…”
Section: Opening Statementmentioning
confidence: 99%